BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/1/2015 7:01:00 PM | Browse: 1209 | Download: 1738
 |
Received |
|
2014-09-12 10:53 |
|
Peer-Review Started |
|
2014-09-13 09:18 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-10-06 22:26 |
|
Revised |
|
2014-12-16 00:00 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-01-14 09:16 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2015-01-20 16:36 |
|
Articles in Press |
|
2015-01-20 16:36 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-04-20 09:23 |
|
Publish the Manuscript Online |
|
2015-05-01 19:01 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Review |
| Article Title |
Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Samantha A Nicholson, Buhle Moyo and Patrick B Arbuthnot |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| South African National Research Foundation (NRF) |
GUNs 81768 |
| South African National Research Foundation (NRF) |
81692 |
| South African National Research Foundation (NRF) |
68339 |
| South African National Research Foundation (NRF) |
85981 |
| South African National Research Foundation (NRF) |
77954 |
| Poliomyelitis Research Foundation |
|
| Claude Leon Foundation (SAN) |
|
| University of the Witwatersrand Research Council (BM) |
|
| Medical Research Council |
|
|
| Corresponding Author |
Patrick B Arbuthnot, Wits/SA MRC Antiviral Gene Therapy Research Unit, School of Pathology, Health Sciences Faculty, University of the Witwatersrand, 7 York Road, Parktown, Private Bag 3, Wits 2050, Johannesburg,
South Africa. patrick.arbuthnot@wits.ac.za
|
| Key Words |
Gene therapy; Zinc fingers; Transcription activator-like effectors; Clustered regularly interspaced short palindromic repeats; Homing endonucleases; Liver diseases |
| Core Tip |
The treatment of liver diseases is varied and often complicated. Gene editing is being developed to treat a variety of chronic disorders and has exciting potential for curing hepatic diseases. Engineering of derivatives of zinc finger proteins, transcription activator-like effectors, homing endonucleases and clustered regularly interspaced palindromic repeats potentially enables sequence-specific gene editing. These DNA binding proteins may be used to alter genes permanently or to influence the epigenetic status of liver cells for therapeutic benefit.
|
| Publish Date |
2015-05-01 19:01 |
| Citation |
Nicholson SA, Moyo B, Arbuthnot PB. Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases. World J Hepatol 2015; 7(6): 859-873 |
| URL |
http://www.wjgnet.com/1948-5182/full/v7/i6/859.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v7.i6.859 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
